Our Story
|
Opharmic Technology is a medtech company with a vision and mission to develop technologies that improve patients well-being by partnering with pharmaceutical companies with technically and clinically meaningful products. Leveraging on our proprietary ultrasound technology, Opharmic offers novel and versatile solutions in drug delivery and therapy in ophthalmology and beyond. Launched in 2021, Opharmic's first platform technology for non-invasive ocular induction - MeticTouch, has attracted pharma partners of various sizes from around the world to test and adopt the novel technology to their new and/or existing products at all stages of drug discovery. Patent protected in over 13 territories covering 30 countries, the needle-less MeticTouch technology enables API of various size and characteristics to reach target sites effectively and efficiently without the need of reformulation. |
|
Awards & Recognitions
|
MassChallenge Switzerland & Healthcare Accelerator Finalist - 2022 (On-going)
MedTech Innovator APAC Grand Prize Winner - 2021 Cambridge Consultants Product Development Award - 2021 Deloitte Raising Star Award - 2017 45th International Exhibition of Invention Geneva - 2017 Prize of the State of Geneva; Prize of ULBS Romania IET Innovation Award Winner (Healthcare) - 2016 Google We Solve for X Moonshot Project Kairos' Society K50 Global Top 50 Startups - 2015 Rice Business Plan Competition Top 6 Semi-finalist - 2015 TiE International Business Plan Competition - 2015 Winner (Hong Kong & Asia); Asia Rising Star Award HKUST 4th Annual One Million Dollar Entrepreneurship Competition 2nd Prize Winner |
|
Media & Press
|
         |